Pubblicazioni

Time to progression is the main predictor of survival in patients with high-risk nonmuscle invasive bladder cancer: Results from a machine learning-based analysis of a large multi-institutional database

2024 - UROLOGIC ONCOLOGY

Porreca, Annamaria; Di Nicola, Marta; Lucarelli, Giuseppe; Dorin, Vartolomei Mihai; Soria, Francesco; Terracciano, Daniela; Mistretta, Francesco Alessandro; Luzzago, Stefano; Buonerba, Carlo; Cantiello, Francesco; Mari, Andrea; Minervini, Andrea; Veccia, Alessandro; Antonelli, Alessandro; Musi, Gennaro; Hurle, Rodolfo; Busetto, Gian Maria; Del Giudice, Francesco; Ferretti, Simone; PerdonÃ , Sisto; Prete, Paola Del; Porreca, Angelo; Bove, Pierluigi; Crisan, Nicolae; Russo, Giorgio Ivan; Damiano, Rocco; Amparore, Daniele; Porpiglia, Francesco; Autorino, Riccardo; Piccinelli, Mattia; Brescia, Antonio; TÄtaru, Sabin Octavian; Crocetto, Felice; Giudice, Arturo Lo; de Cobelli, Ottavio; Schips, Luigi; Ferro, Matteo; Marchioni, Michele

Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT Study

2023 - NEUROENDOCRINOLOGY

Ferolla, Piero; Berruti, Alfredo; Spada, Francesca; Brizzi, Maria Pia; Ibrahim, Toni; Marconcini, Riccardo; Giuffrida, Dario; Amoroso, Vito; La Salvia, Anna; Vaccaro, Vanja; Faggiano, Antongiulio; Colao, Annamaria; Volante, Marco; Ghizzoni, Simona; Mazzanti, Paola; Houchard, Aude; Fazio, Nicola

Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis

2023 - JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

De Virgilio, Armando; Costantino, Andrea; Festa, Bianca Maria; Mercante, Giuseppe; Franceschini, Davide; Franzese, Ciro; Scorsetti, Marta; Marrari, Andrea; Cavina, Raffaele; Marano, Salvatore; Castoro, Carlo; Spriano, Giuseppe

Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis

2022 - CANCERS

Del Giudice, F.; Flammia, R. S.; Chung, B. I.; Moschini, M.; Pradere, B.; Mari, A.; Soria, F.; Albisinni, S.; Krajewski, W.; Szydelko, T.; Laukhtina, E.; D'Andrea, D.; Gallioli, A.; Mertens, L. S.; Maggi, M.; Sciarra, A.; Salciccia, S.; Ferro, M.; Scornajenghi, C. M.; Asero, V.; Cattarino, S.; Angelis, M. D.; Cacciamani, G. E.; Autorino, R.; Pandolfo, S. D.; Falagario, U. G.; D'Altilia, N.; Mancini, V.; Chirico, M.; Cinelli, F.; Bettocchi, C.; Cormio, L.; Carrieri, G.; De Berardinis, E.; Busetto, G. M.

Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature

2022 - CANCER TREATMENT REVIEWS

Lombardi, P.; Rossini, D.; Crespi, V.; Germani, M. M.; Bergamo, F.; Pietrantonio, F.; Santini, D.; Allegrini, G.; Daniel, F.; Pagani, F.; Antoniotti, C.; Zaniboni, A.; Conca, V.; Latiano, T. P.; Boccaccino, A.; Passardi, A.; Tamburini, E.; Masi, G.; Di Maio, M.; Cremolini, C.

Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis

2021 - JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Del Giudice, Francesco; Busetto, Gian Maria; Gross, Martin S; Maggi, Martina; Sciarra, Alessandro; Salciccia, Stefano; Ferro, Matteo; Sperduti, Isabella; Flammia, Simone; Canale, Vittorio; Chung, Benjamin I; Conti, Simon L; Eisenberg, Michael L; Skinner, Eila C; De Berardinis, Ettore

The role of secondary cytoreductive surgery in recurrent ovarian cancer: a systematic review and meta-analysis

2021 - ANNALS OF SURGICAL ONCOLOGY

Marchetti, C.; Fagotti, A.; Tombolini, V.; Scambia, G.; De Felice, F.

Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO

2021 - BRITISH JOURNAL OF CANCER

Rossini, D.; Lonardi, S.; Antoniotti, C.; Santini, D.; Tomasello, G.; Ermacora, P.; Germani, M. M.; Bergamo, F.; Ricci, V.; Caponnetto, S.; Moretto, R.; Zaniboni, A.; Pietrantonio, F.; Buonadonna, A.; Ritorto, G.; Masi, G.; Latiano, T. P.; Rapisardi, S.; Falcone, A.; Cremolini, C.

Vemurafenib plus rituximab in refractory or relapsed hairy-cell leukemia

2021 - NEW ENGLAND JOURNAL OF MEDICINE

Tiacci, E.; De Carolis, L.; Simonetti, E.; Capponi, M.; Ambrosetti, A.; Lucia, E.; Antolino, A.; Pulsoni, A.; Ferrari, S.; Zinzani, P. L.; Ascani, S.; Perriello, V. M.; Rigacci, L.; Gaidano, G.; Seta, R. D.; Frattarelli, N.; Falcucci, P.; Foa, R.; Visani, G.; Zaja, F.; Falini, B.

A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations

2021 - CLINICAL & TRANSLATIONAL ONCOLOGY

Alongi, F.; Nicosia, L.; Figlia, V.; De Sanctis, V.; Mazzola, R.; Giaj-Levra, N.; Reverberi, C.; Valeriani, M.; Osti, M. F.

Second-line eribulin in triple negative metastatic breast cancer patients. Multicentre retrospective study: The tetris trial

2021 - INTERNATIONAL JOURNAL OF MEDICAL SCIENCES

Krasniqi, E.; Pizzuti, L.; Valerio, M. R.; Capomolla, E.; Botti, C.; Sanguineti, G.; Marchetti, P.; Anselmi, E.; Tomao, S.; Giordano, A.; Ficorella, C.; Cannita, K.; Livi, L.; Meattini, I.; Mauri, M.; Greco, F.; Veltri, E. M.; Michelotti, A.; Moscetti, L.; Giotta, F.; Lorusso, V.; Paris, I.; Tomao, F.; Santini, D.; Tonini, G.; Villa, A.; Gebbia, V.; Gamucci, T.; Ciliberto, G.; Sperduti, I.; Mazzotta, M.; Barba, M.; Vici, P.

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Lawless, S; Sbianchi, G; Morris, C; Iacobelli, S; Bosman, P; Blaise, D; Remenyi, P; Byrne, Jl; Mayer, J; Apperley, J; Lund, J; Kobbe, G; Schaap, N; Isaksson, C; Lenhoff, S; Basak, G; Touzeau, C; Wilson, Kmo; Muniz, Sg; Scheid, C; Browne, P; Anagnostopoulos, A; Rambaldi, A; Jantunen, E; Kroger, N; Schonland, S; Yakoub-Agha, I; Garderet, L

Efficacy and tolerability of selective internal radiotherapy with Yttrium-90 as consolidation treatment after chemotherapy in metastatic colorectal cancer

2020 - CLINICAL COLORECTAL CANCER

Cortesi, E.; Caponnetto, S.; Masi, G.; Urbano, F.; Mezi, S.; Gelibter, A.; Pelle, G.; Filippi, L.; Cianni, R.

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of â¥ 50%

2020 - CANCER IMMUNOLOGY, IMMUNOTHERAPY

Cortellini, A.; Tiseo, M.; Banna, G. L.; Cappuzzo, F.; Aerts, J. G. J. V.; Barbieri, F.; Giusti, R.; Bria, E.; Cortinovis, D.; Grossi, F.; Migliorino, M. R.; Galetta, D.; Passiglia, F.; Santini, D.; Berardi, R.; Morabito, A.; Genova, C.; Mazzoni, F.; Di Noia, V.; Signorelli, D.; Tuzi, A.; Gelibter, A.; Marchetti, P.; Macerelli, M.; Rastelli, F.; Chiari, R.; Rocco, D.; Gori, S.; De Tursi, M.; Mansueto, G.; Zoratto, F.; Santoni, M.; Tudini, M.; Rijavec, E.; Filetti, M.; Catino, A.; Pizzutilo, P.; Sala, L.; Citarella, F.; Marco, R.; Torniai, M.; Cantini, L.; Targato, G.; Sforza, V.; Nigro, O.; Ferrara, M. G.; D'Argento, E.; Buti, S.; Bordi, P.; Antonuzzo, L.; Scodes, S.; Landi, L.; Guaitoli, G.; Baldessari, C.; Della Gravara, L.; Dal Bello, M. G.; Belderbos, R. A.; Bironzo, P.; Carnio, S.; Ricciardi, S.; Grieco, A.; De Toma, A.; Proto, C.; Friedlaender, A.; Cantale, O.; Ricciuti, B.; Addeo, A.; Metro, G.; Ficorella, C.; Porzio, G.

Post-mastectomy immediate breast reconstruction and adjuvant radiotherapy: long term results of a mono institutional experience

2020 - LA RADIOLOGIA MEDICA

Reverberi, C.; Marinelli, L.; Campanella, B.; Scalabrino, G.; Nicosia, L.; Anzellini, D.; De Sanctis, V.; Valeriani, M.; Osti, M. F.

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity

2019 - JOURNAL FOR IMMUNOTHERAPY OF CANCER

Minniti, G.; Anzellini, D.; Reverberi, C.; Cappellini, G. C. A.; Marchetti, L.; Bianciardi, F.; Bozzao, A.; Osti, M.; Gentile, P. C.; Esposito, V.

Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?

2019 - ANNALS OF NUCLEAR MEDICINE

Chiaravalloti, A.; Esposito, V.; Ursini, F.; Di Giorgio, E.; Zinzi, M.; Calabria, F.; Cimini, A.; Schillaci, O.

Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3Â Gy/fraction)

2019 - LA RADIOLOGIA MEDICA

Valeriani, M.; Marinelli, L.; Nicosia, L.; Reverberi, C.; De Sanctis, V.; Mollo, D.; Osti, M. F.

Inoperable early-stage primary and early recurrent non-small cell lung cancer: outcomes of a mono-institutional experience using a moderate hypofractionated schedule

2019 - LA RADIOLOGIA MEDICA

Valeriani, M.; Marinelli, L.; Reverberi, C.; De Sanctis, V.; Mollo, D.; Nicosia, L.; Osti, M. F.

Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial

2019 - JAMA ONCOLOGY

Cremolini, C; Rossini, D; Dell'Aquila, E; Lonardi, S; Conca, E; Del Re, M; Busico, A; Pietrantonio, F; Danesi, R; Aprile, G; Tamburini, E; Barone, C; Masi, G; Pantano, F; Pucci, F; Corsi, Dc; Pella, N; Bergamo, F; Rofi, E; Barbara, C; Falcone, A; Santini, D

Relationship and predictive role of the dual expression of FGFR and IL-8 in metastatic renal cell carcinoma treated with targeted agents

2018 - ANTICANCER RESEARCH

Iacovelli, Roberto; De Tursi, Michele; Mosillo, Claudia; Ciardi, Antonio; Carella, Consiglia; Natoli, Clara; Naso, Giuseppe; Cortesi, Enrico

Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab

2018 - CANCER BIOLOGY & THERAPY

Pizzuti, L.; Sergi, D.; Sperduti, I.; Lauro, L. D.; Mazzotta, M.; Botti, C.; Izzo, F.; Marchetti, L.; Tomao, S.; Marchetti, P.; Natoli, C.; Grassadonia, A.; Gamucci, T.; Mentuccia, L.; Magnolfi, E.; Vaccaro, Andrea; Cassano, A.; Rossi, E.; Botticelli, A.; Sini, V.; Sarobba, M. G.; Fabbri, M. A.; Moscetti, L.; Astone, A.; Michelotti, A.; De Angelis, C.; Bertolini, I.; Angelini, F.; Ciliberto, G.; Maugeri-Sacca, M.; Giordano, A.; Barba, M.; Vici, P.

1.5-T Field Intraoperative Magnetic Resonance Imaging Improves Extent of Resection and Survival in Glioblastoma Removal

2017 - WORLD NEUROSURGERY

Marongiu, Alessandra; D'Andrea, Giancarlo; Raco, Antonino

Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis

2015 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Bria, E.; Massari, F.; Maines, F.; Pilotto, S.; Bonomi, M.; Porta, C.; Bracarda, S.; Heng, D.; Santini, D.; Sperduti, I.; Giannarelli, D.; Cognetti, F.; Tortora, G.; Milella, M.